{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-029936","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2024-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.193002+00:00","generated_at":"2026-06-01T02:08:34.353254+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ChromaDex CFO Brianna Gerber resigns effective July 12; consulting transition through Aug 12","bullets":["CFO & CAO Brianna Gerber resigns effective July 12, 2024; company beginning search for replacement.","Post-resignation consulting agreement through Aug 12, 2024; $1,000 consulting fee.","Outstanding stock options and RSUs continue to vest during consulting period per existing equity plan terms.","Gerber confirms resignation is without Good Reason; no severance benefits under employment agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-029936","json":"https://secwatch.observer/filing/0001628280-24-029936.json","markdown":"https://secwatch.observer/filing/0001628280-24-029936.md","text":"https://secwatch.observer/filing/0001628280-24-029936.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000162828024029936/0001628280-24-029936-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000162828024029936/cdxc-20240619.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:08:34.353254+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"53922cea66","claim":"Brianna Gerber departed as Chief Financial Officer and Chief Accounting Officer at Niagen Bioscience, Inc..","evidence_excerpt":"On June 19, 2024, Brianna Gerber, the Chief Financial Officer and Chief Accounting Officer of ChromaDex Corporation (the “Company”), informed the Company that she will be resigning from her roles with the Company, effective July 12, 2024 (the “Separation Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828024029936/0001628280-24-029936-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigning"},{"label":"Role","value":"Chief Financial Officer and Chief Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}